Intravenous lidocaine infusions for chronic pain are associated with a low incidence of serious adverse events, according to recent study results.
Adults who received the updated mRNA-1273 COVID-19 vaccine experienced a lower risk for hospitalization compared with NVX-CoV2705 recipients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results